Place of combination drugs in the therapy of acute bronchitis in children

Acute respiratory tract infections accompanied by cough play a significant role in respiratory pathology in childhood. The incidence of acute respiratory infections among children is 4–5 times higher than among the adult population and accounts for more than 90% of all infectious and parasitic diseases registered in Russia. The highest rates of acute respiratory infections are observed among children of preschool age, especially in the first three years of life. As in adults, children’s cough, described as a symptom of «upper respiratory infection» or «acute bronchitis», is the most commonly diagnosed acute manifestation in primary care. These 2 diagnoses represent 75% of all cough cases. The most common etiological agents in acute bronchitis are respiratory viruses: adenovirus, influenza viruses and parainfluenza viruses, respiratory syncytial virus, rhinovirus, human Bocavirus, Coxsackievirus, herpes simplex virus, etc. Drug therapy for coughing is prescribed when there is a nonproductive cough that does not perform its protective function, meaning it does not contribute to the purification of the respiratory tract, and is aimed at dilution of sputum, reducing its adhesiveness (viscosity) and thus increase the effectiveness of coughing. The main groups of mucoactive drugs that are usually considered in this case are mucolytics, mucoregulators, mucokinetics, expectorants, and combination drugs. Combination drugs created to eliminate various elements of pathogenesis of respiratory diseases, accompanied by a nonproductive cough and bronchoobstruction, deserve close attention due to the possibility of using several active substances in fixed drug combinations with accurate dosages and proven clinical effectiveness, reducing the number of simultaneously taken drugs, reducing the risk of developing undesirable events. Oral administration of combined medicines becomes especially important in conditions when inhalation therapy is impossible.

acute respiratory infections, children, moccoactive drugs, combination drugs, acute bronchitis, ascoril expectorant

1. Geppe N.A., Kozlova L.V., Gorelov A.V., Kondyurina E.G., Malakhov A.B., Ilienkova N.A. Acute respiratory tract infections in children. Diagnostics, treatment, prevention: clinical guidelines. Moscow: MedCom-Pro; 2018. 200 p. (In Russ.)

2. O’Grady K.F., Grimwood K., Sloots T.P., Whiley D.M., Acworth J. P., Phillips N. et al. Upper airway viruses and bacteria and clinical outcomes in children with cough. Pediatr Pulmonol. 2017;52(3):373–381. doi: 10.1002/ppul.23527.

3. Geppe N.A., Malakhov A.B (ed.). Complex approach to the treatment and prevention of acute respiratory infections in children: a practical guide for physicians. Moscow; 2012. 47 p.

4. Hay A.D., Wilson A.D. The natural history of acute cough in children aged 0 to 4 years in primary care: a systematic review. Br J Gen Pract. 2002;52(478):401–409. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314298/pdf/12014540.pdf.

5. Jurca M., Ramette A., Dogaru C.M., Goutaki M., Spycher B.D., Latzin Ph. еt al. Prevalence of cough throughout childhood: A cohort study. PLoS One. 2017;12(5):e0177485. doi: 10.1371/journal.pone.0177485.

6. Worrall G. Acute cough in children. Can Fam Physician. 2011;57(3):315–318. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056681/pdf/0570315.pdf.

7. Whitburn S., Costelloe C., Montgomery A.A., Redmond N. M., Fletcher M., Peters T.J., Hay A.D. The frequency distribution of presenting symptoms in children aged six mo nths to six years to primary care. Prim Health Care Res Dev. 2011;12(2):123–134. doi: 10.1017/S146342361000040X.

8. Baranov A.A., Namazova-Baranova L.S., Tatochenko V.K., Bakradze M.D., Polyakova A.S., Kulichenko T.V. et al. Acute Bronchitis in Children (КР381). 2018. (In Russ.) Available at: https://library.mededtech.ru/rest/documents/cr_239/

9. Dronov I.A., Malakhov A.B. Antibacterial therapy for acute respiratory infections in children. Pediatriya. Prilozhenie k zhurnalu Consilium Medicum = Pediatrics. Appendix to the journal Consilium Medicum. 2017;(04):31–35. (In Russ.) Available at: https://elibrary.ru/item.asp?id=32303527.

10. Stokes D.C., Dozor A.J. Pediatric Pulmonology, Asthma, and Sleep Medicine. Elk Grove Village, United States: American Academy of Pediatrics; 2018. 890 p.

11. Geppe N.A., Malakhov A.B., Zaytseva O.V., Degtyareva M.V., Ilyenkova N.A., Kalyuzhin O.V. Controversial and unresolved issues in the treatment of cough in children in outpatient practice. Pediatriya. Prilozhenie k zhurnalu Consilium Medicum = Pediatrics. Appendix to the journal Consilium Medicum. 2017;(4):40–45. (In Russ.) Available at: https://elibrary.ru/item.asp?id=32303529.

12. Knyazheskaya N.P., Bokov E.V., Tatarskiy A.R. Combined drug Ascoril in the therapy of cough and bronchoobstruction. RMZH = RMJ. 2013;(7):368–370. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/kombinirovannyy_preparat_askoril_v_terapii_kashlya_i_bronhoobstrukcii/.

13. Malakhov A.B., Dronov I.A., Shakhnazarova M.D. Efficacy and safety of using combined medication (bromhexine + guaifenesin + salbutamol) for treating the acute respiratory infections in children. Pediatriya. Prilozhenie k zhurnalu Consilium Medicum = Pediatrics. Appendix to the journal Consilium Medicum. 2016;(01):65–69. (In Russ.) Available at: https://elibrary.ru/item.asp?id=27379796.

14. Prabhu Shankar S., Chandrashekharan S., Bolmall C.S., Baliga V. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study. J Indian Med Assoc. 2010;108(5):313–320. Available at: https://www.altmetric.com/details/1598558.

15. Geppe N.A., Seliverstova N.A., Utyusheva M.G. Application of combined therapy in the treatment of acute respiratory diseases in children. Ehffektivnaya farmakoterapiya. Pediatriya = Effective Pharmacotherapy. Pediatria. 2011;(1). Available at: https://umedp.ru/articles/primenenie_kombinirovannoy_terapii_pri_lechenii_ostrykh_respiratornykh_zabolevaniy_u_detey.html.